US 10350162
Methods and compositions for oral administration of exenatide
granted A61KA61K31/202A61K31/22
Quick answer
US patent 10350162 (Methods and compositions for oral administration of exenatide) held by Oramed Ltd. expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oramed Ltd.
- Grant date
- Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/202, A61K31/22, A61K38/26, A61K38/56